Login to Your Account

Inovio, Wyeth Enter Potential $64.5M Pact On Drug Delivery

By Randall Osborne

Wednesday, November 8, 2006
Wyeth juiced Inovio Biomedical Corp.'s bottom line with a potential $64.5 million, nonexclusive licensing deal that gives the pharma giant rights to use MedPulser electroporation delivery technology in DNA vaccines. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription